Trial Profile
Study of Eylea in patients with wet age-related macular degeneration
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Sep 2018
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Wet age-related macular degeneration
- Focus Therapeutic Use
- 11 Sep 2018 New trial record
- 01 Aug 2018 Results (n=48) published in the Medicine